Previous Article | Next Article 
Antimicrob Agents Chemother. 1984 August; 26(2): 250-255
Lipopolysaccharide changes in impermeability-type aminoglycoside resistance in Pseudomonas aeruginosa.
L E Bryan,
K O'Hara and
S Wong
ABSTRACT
Clinical isolates of Pseudomonas aeruginosa were examined for the basis of impermeability-type aminoglycoside resistance. Two apparently related burn isolate strains with high-level (strain 8803) and low-level (strain 13934) gentamicin resistance each had a plasmid. Transformation of the plasmid from either strain to P. aeruginosa PAO503 resulted in low-level gentamicin resistance. No mechanism for this resistance could be determined. Low-level gentamicin and streptomycin resistance from strain 8803 (but not 13934) was transduced with phage E79.tv2 to PAO503 without transfer of plasmid DNA. Transductants like strain 8803 showed absence or reduction of the lipopolysaccharide (LPS) "ladder" pattern of PAO503, had a change in chemical composition of LPS, and, like strain 8803, had a reduced capability to accumulate streptomycin. Comparison of the resistant clinical isolates 8803 and P10 with the apparently related but less-resistant strains 13934 and P10R, respectively, showed the latter strains had LPS ladder patterns and the former strains did not. Strain 8803 had normal outer membrane protein profiles, electron transport components, and transmembrane electrical potential relative to PAO503 and has been previously shown to have no detectable gentamicin-modifying enzymes and normal protein synthesis. We conclude that low-level impermeability-type aminoglycoside resistance in P. aeruginosa results from conversion of smooth LPS to superficial or deeper rough LPS phenotypes. High-level resistance apparently results from a plasmid-specified, but as yet unknown, mechanism combined with the preceding change in LPS structure.
Antimicrob Agents Chemother. 1984 August; 26(2): 250-255
This article has been cited by other articles:
-
Lerner, A., Okon, Y., Burdman, S.
(2009). The wzm gene located on the pRhico plasmid of Azospirillum brasilense Sp7 is involved in lipopolysaccharide synthesis. Microbiology
155: 791-804
[Abstract]
[Full Text]
-
Atabek, A., Camesano, T. A.
(2007). Atomic Force Microscopy Study of the Effect of Lipopolysaccharides and Extracellular Polymers on Adhesion of Pseudomonas aeruginosa. J. Bacteriol.
189: 8503-8509
[Abstract]
[Full Text]
-
El'Garch, F., Jeannot, K., Hocquet, D., Llanes-Barakat, C., Plesiat, P.
(2007). Cumulative Effects of Several Nonenzymatic Mechanisms on the Resistance of Pseudomonas aeruginosa to Aminoglycosides. Antimicrob. Agents Chemother.
51: 1016-1021
[Abstract]
[Full Text]
-
Struble, J. M., Gill, R. T.
(2006). Reverse Engineering Antibiotic Sensitivity in a Multidrug-Resistant Pseudomonas aeruginosa Isolate.. Antimicrob. Agents Chemother.
50: 2506-2515
[Abstract]
[Full Text]
-
Poole, K.
(2005). Aminoglycoside Resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother.
49: 479-487
[Full Text]
-
McKay, G. A., Woods, D. E., MacDonald, K. L., Poole, K.
(2003). Role of Phosphoglucomutase of Stenotrophomonasmaltophilia in Lipopolysaccharide Biosynthesis, Virulence, and Antibiotic Resistance. Infect. Immun.
71: 3068-3075
[Abstract]
[Full Text]
-
Wang, Y., Ha, U., Zeng, L., Jin, S.
(2003). Regulation of Membrane Permeability by a Two-Component Regulatory System in Pseudomonas aeruginosa. Antimicrob. Agents Chemother.
47: 95-101
[Abstract]
[Full Text]
-
Westbrock-Wadman, S., Sherman, D. R., Hickey, M. J., Coulter, S. N., Zhu, Y. Q., Warrener, P., Nguyen, L. Y., Shawar, R. M., Folger, K. R., Stover, C. K.
(1999). Characterization of a Pseudomonas aeruginosa Efflux Pump Contributing to Aminoglycoside Impermeability. Antimicrob. Agents Chemother.
43: 2975-2983
[Abstract]
[Full Text]
-
Rocchetta, H. L., Burrows, L. L., Lam, J. S.
(1999). Genetics of O-Antigen Biosynthesis in Pseudomonas aeruginosa. Microbiol. Mol. Biol. Rev.
63: 523-553
[Abstract]
[Full Text]
-
Maloney, J., Rimland, D., Stephens, D. S., Terry, P., Whitney, A. M.
(1989). Analysis of Amikacin-Resistant Pseudomonas aeruginosa Developing in Patients Receiving Amikacin. Arch Intern Med
149: 630-634
[Abstract]